Previous Article | Next Article ![]()
Infection and Immunity, August 1999, p. 4191-4200, Vol. 67, No. 8
Department of Clinical Studies, University of
Pennsylvania, Philadelphia, Pennsylvania 19104-6010
Received 4 February 1999/Returned for modification 29 March
1999/Accepted 16 April 1999
Heat shock protein 60 (hsp60) is constitutively expressed in the
mitochondria of eukaryotic cells. However, it has been identified in
other subcellular compartments in several disease states and in
transformed cells, and it is an immunogenic molecule in various infectious and autoimmune diseases. To better understand the factors that influence expression of hsp60 in normal cells in vivo, we analyzed
its cellular and subcellular distribution in mice infected with the
intracellular bacterium Listeria monocytogenes. Western blotting of subcellular fractionated spleen cells showed that although
endogenous hsp60 was restricted to the mitochondria in noninfected
animals, it was associated with the plasma membrane as a result of
infection. The low levels of plasma membrane-associated hsp60 seen in
the livers in noninfected animals subsequently increased during
infection. Plasma membrane hsp60 expression did not correlate with
bacterial growth, being most evident during or after bacterial clearance and persisting at 3 weeks postinfection. Using flow cytometry, we determined that Mac-1+, T-cell receptor
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Plasma Membrane Expression of Heat Shock Protein 60 In Vivo in Response to Infection


+, and B220+ cells represented the major
Hsp60+ populations in spleens of infected mice. By
contrast, B220+ cells were the predominant
hsp60+ population in livers of infected mice. Of the immune
cells analyzed, the kinetic profile of the 
T-cell response most
closely matched that of hsp60 expression in both the spleen and liver.
Collectively, these findings show that during infection hsp60 can be
localized to the plasma membrane of viable cells, particularly
antigen-presenting cells, providing a means by which hsp60-reactive
lymphocytes seen in various infectious disease and autoimmune disorders
may be generated and maintained.
*
Corresponding author. Mailing address: Department of
Clinical Studies, University of Pennsylvania School of Veterinary
Medicine, 3900 Delancy St., Philadelphia, PA 19104-6010. Phone: (215)
573-3022. Fax: (215) 573-6168. E-mail:
carding{at}vet.upenn.edu.
Present address: University of Colorado Health Science Center,
Denver, CO 80262.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|